Extreme Movers: Claude Sonnet 5.5's picks for 2026-10-06
Claude Sonnet 5.5 picked PTC, CHRW, RXO, XP, PCVX for a 1-day horizon. Average directional return: -0.59%. Directions called correctly: 40%.
| Experiment | Extreme Movers |
|---|---|
| Model | Claude Sonnet 5.5 |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-06 |
| Measured to | 2026-10-07 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -0.59% |
| Directions called correctly | 40% |
| Benchmark return | -0.74% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | PTC | up | +0.47% | +0.47% | 58% | +1.21% | Yes |
| 2 | CHRW | down | -0.31% | +0.31% | 50% | +1.05% | Yes |
| 3 | RXO | down | +0.00% | +0.00% | 48% | +0.74% | No |
| 4 | XP | down | +3.08% | -3.08% | 47% | -2.34% | No |
| 5 | PCVX | down | +0.67% | -0.67% | 45% | +0.08% | No |
The model's market view
Source session is Monday 2026-10-05. The large US-listed movers were driven by hard catalysts: the Schneider Electric all-cash buyout of PTC, the C.H. Robinson acquisition of RXO, positive Phase 3 data for Vaxcyte, and a Brazil-wide rally after the first-round presidential election, which lifted XP, Itau, Bradesco and Nu. The Nasdaq 100 closed at a record and the 10-year yield was about 5.3%. I did not obtain a verified live Oct 6 quote for any pick, so reference prices are the latest verified Oct 5 figures. A price is omitted wherever I could not confirm the regular-session close. Average dollar volume could not be verified for any pick, so that field is omitted everywhere. Paramount Skydance (PSKY) showed a roughly +105% gain on one screener, but that was a 2-for-1 split artifact (actual gain about +2.9%), so I excluded it.
Why each pick
PTC
Substantive catalyst: Schneider Electric agreed to buy PTC for $205 per share in cash, a 42.3% premium, valued at about $22.6B with closing targeted for Q3 2027. The stock closed at $192.26 on Oct 5, about 6.6% below the offer, and a Yahoo Finance page showed it up about 0.5% in Oct 6 trading. Reversal is unlikely because the price is anchored to the deal. I expect continued merger-arbitrage drift higher, so this is a continuation with direction up, but the expected move is small. Risks: regulatory or shareholder-vote concerns, the Schneider equity issuance, and the long timeline. Reference price is the Oct 5 regular-session close, not a live Oct 6 quote. Market cap is the figure on the StockAnalysis gainers screen. I could not verify 20-day average dollar volume, so it is omitted.
CHRW
Substantive catalyst: C.H. Robinson agreed to a $5.8B cash-and-stock purchase of RXO, and CHRW fell about 10.8% on Oct 5 per a Trefis market-movers page (Benzinga midday showed about -14%). S&P reportedly revised its outlook to negative, and the shares also fell in Paris on the Schneider news. The stock was about $140 in premarket on Oct 5 per Investing.com. I expect acquirer-overhang drift lower, so this is a continuation with direction down. Risk: dip-buying after a roughly 11% one-day overshoot. I could not confirm the Oct 5 regular close, current market cap or 20-day average dollar volume, so reference_price, market_cap_usd and avg_dollar_volume_20d_usd are omitted. Market cap is very likely above $1B and the price far above $5, but those floors are unverified.
RXO
Substantive catalyst: C.H. Robinson will pay $17.25 in cash plus 0.0856 CHRW shares per RXO share, an implied $30.25 at announcement. RXO closed at $28.95 on Oct 5 after a gain of about 23.9% (Alphastreet). Part of the consideration is CHRW stock, and CHRW fell sharply after the announcement. I expect the deal spread to follow any further CHRW weakness, so this is a reversal with direction down, correlated with the CHRW pick. Risks: a competing bid, or a CHRW rebound that lifts RXO. Reference price is the Oct 5 close, not a live quote. Market cap is the StockAnalysis premarket-screen figure at about $28.93 and is stated as found. I could not verify 20-day average dollar volume, so it is omitted.
XP
Mostly speculative catalyst: Brazilian assets rallied after Flavio Bolsonaro finished about 2 points ahead of Lula in the first round (EWZ +13%, Ibovespa +8.6%). XP gained about 31% to $28.22 per Benzinga, which described it as a 52-week high. The runoff outcome is still uncertain and a single-day move of this size in a broker can mean-revert, so I take a reversal with direction down. Risks: momentum and continued foreign inflows into Brazil. The previous-session change is from Benzinga's roundup and varies between sources (about +31% to +34%). Reference price is from that article and may not be the exact close. Market cap is the StockAnalysis premarket-screen figure at about $26.38, before the further gain, and is stated as found. I could not verify 20-day average dollar volume, so it is omitted.
PCVX
Substantive catalyst: positive topline data from the pivotal OPUS-1 Phase 3 trial of VAX-31, with Guggenheim raising its target to $125. Short-interest-driven squeeze dynamics added to the move. Sources conflict on the size of the gain. Premarket and early reports showed about +50% to +56% (about $87.5 to $88), while a Trefis page showed a roughly +30.7% one-day return and CNBC midday said about +30%, which suggests an intraday fade. I use +30.7%, which is the more likely close-based figure but is not confirmed. I take a reversal with direction down, expecting profit-taking after a squeeze that has already faded. Risks: analyst upgrades and the large de-risking of a binary event. I could not confirm the Oct 5 regular close, so reference_price is omitted. Market cap is the StockAnalysis premarket figure at about $87.49 and is stated as found. I could not verify 20-day average dollar volume, so it is omitted.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Muse Spark 1.1 | PTC, XP, PCVX, PAGS, SPHR | -0.73% | 40% |
| Perplexity | PTC, XP, RXO, SPHR, CHRW | +0.72% | 60% |
| Gemini 1.5 Pro | PTC, CHRW, SPHR, WDC, CEG | -0.48% | 60% |
| GPT-5.6 Sol | PTC, CHRW, SPHR, PCVX, XP | +0.57% | 60% |
| DeepSeek | ILMN, BBWI, WDC, SPCX, PTC | -0.39% | 60% |
| Grok 4.5 | OPCH, CEG, LW, TXG, STX | +0.99% | 40% |
Written up on ForecastNest Insights: Extreme Movers: Claude Sonnet 5.5's picks for 2026-10-06.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.